Drugs / Intestinal Microbiota Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02301000 | Feb 2015 → Nov 2017 | Clostridium difficile colitis | Oslo University Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intestinal Microbiota Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02301000 ↗ |
| Known as | Anaerobically cultivated human intestinal microbiota | “Anaerobically cultivated human intestinal microbiota” NCT02301000 ↗ |
| Route | Rectal | “60 ml of ACHIM suspension will be administered through a rectal tube” NCT02301000 ↗ |